SCHEMBL21167710

SCHEMBL21167710

COc1ccc(Nc2ccc(N)c(N(N)Cc3ccc4ncccc4c3)n2)nc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 1/20 0.37
CLK2 P49760 1/20 0.37
DYRK1A Q13627 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
MAPT P10636 1/20 0.37
PDE10A Q9Y233 2/20 0.37
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
HDAC3 O15379 1/20 0.36
BRAF P15056 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
MET P08581 3/20 0.35
QPCT Q16769 1/20 0.35
IGF1R P08069 2/20 0.35
HSF1 Q00613 1/20 0.35
KDR P35968 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167711 0.81 KDR (0.42) CLK1CLK2DYRK1ACLK4DYRK1B
SCHEMBL22475982 0.79 ABCB1 (0.39) MAPTNPC1HDAC3ALDH1A1MET
SCHEMBL24591153 0.79 GSK3A (0.39) CLK1CLK2DYRK1ACLK4DYRK1B
SCHEMBL16882503 0.78 BRAF (0.40) CLK1CLK2DYRK1ACLK4DYRK1B
SCHEMBL21167654 0.76 PDE10A (0.40) CLK1CLK2DYRK1ACLK4DYRK1B
SCHEMBL21167331 0.76 SYK (0.37) CLK1CLK2DYRK1ACLK4DYRK1B
SCHEMBL12486158 0.75 PDE10A (0.39) CLK1CLK2DYRK1ACLK4DYRK1B
SCHEMBL21167377 0.75 MAT2A (0.39) DYRK1APDE10AHDAC3MET
SCHEMBL22475868 0.75 HDAC3 (0.37) DYRK1APDE10ARAB9ANPC1HDAC3
SCHEMBL22475688 0.74 HDAC3 (0.42) HDAC3MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed